CRMDCorMedix Inc.

Healthcare

$7.31-34% 1Y

$7.31

$6.2552 weeks$12.73

Price

-34%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

Quality strong, a flag to check, undemanding price, growing in the filings, the market against it.

RyuScore 60 of 100: see how it is built

P/E3.6

Market value$573.5M

1 year-34%

5 years+57%

Charts

As reported to the SEC, without any scoring.

CorMedix Inc. (CRMD) reported revenue of $102M in Q2 2026 (quarter ended Jun 30, 2026), up 157% from the same quarter a year earlier. That came with a gross margin of 76% and net income of $26M (25% of revenue). For the full year FY2025, revenue was $312M (+617% year on year) and net income $163M. The next results filing is expected around Nov 11, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 7, 2026On July 24, 2026, the U.S. District Court for the District of New Jersey (the “District Court”) issued an order granting preliminary approval of the proposed settlement of the consolidated derivative lawsuit captioned In re CorMedix Inc. Derivative Litigation, Case No. 2:21-cv-18493-JXN-LDW (D.N.J) and a related …Other event · Form 8-K
Jul 2, 2026On June 29, 2026, CorMedix Inc. (the “Company”) effected a change in its executive leadership structure, whereby the Company’s Board of Directors has appointed Elizabeth Hurlburt, currently the Chief Operating Officer, to the newly created role of Chief Operating and Commercial Officer where she will have functional …Other event · Form 8-K
Jul 1, 2026Dismissal of Independent Registered Public Accounting Firm On June 25, 2026, the Audit Committee of the Board of Directors of CorMedix Inc. (the “Company”) approved the decision to change its independent registered public accounting firm and dismissed CBIZ CPAs P.C. (“CBIZ CPAs”) as the Company’s independent …Auditor change · Form 8-K